Life and Health Insurance

Manulife Financial

Manulife Private Credit Enhanced Fund Proposes Share Repurchase Up to $11.4 Million

Manulife Singapore to Launch Shield™ Multi-Cancer Test with Guardant Health in May 2026

Manulife Reports Q1 Core Profit of 1.8 Billion Canadian Dollars

Manulife Financial released FY2026 Q1 earnings on May 13 After-Market EST, actual revenue USD 6.991 B (forecast USD 5.304 B), actual EPS USD 0.4666 (forecast USD 0.6223)

Manulife Reports First Quarter 2026 Results

Manulife Financial to Release FY2026 Q1 Earnings on May 13 After-Market EST, Forecast Revenue USD 5.304 B, EPS USD 0.6382

Manulife Reduces Management Fees for MPF Plans Benefiting Over 2 Million Members

Manulife Holding Annual Shareholder and Policyholder Meeting in 2026

Manulife Establishes Long-Term Partnership with Legal & General and Appoints New AI Data Officer

L&G and Manulife Wealth and Asset Management Establish Global Strategic Partnership

Manulife Plans to Expand AI Investment in Hong Kong

Guardant Health Partners with Manulife Financial to Launch Shield Multi-Cancer Blood Test in Asia

Manulife Chooses Akka to Implement Agent AI

Sienna Gestion Increased Holdings in Manulife Financial in Q3

Manulife Vietnam Launches Xanh Phu Quy Investment-Linked Life Insurance Product

Manulife Holdings Announces Q4 Earnings and Final Dividend

Manulife Singapore Issues a $300 Million Indexed Universal Life Insurance Policy

Manulife Sells $300 Million Life Insurance Policy, Sets Guinness Record

Mahindra & Mahindra and Manulife Establish 50:50 Life Insurance Joint Venture in India

CFRA Maintains Manulife Financial's Buy Rating and Raises Target Price to $42

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Ordinary dividend (cash)

Ex Date: 2026.05.29 (EST), Cash dividend 0.485 CAD

John Hancock Closed-End Funds announced earnings for the three months ending April 30, 2026. Key figures include net investment income and per common share earnings for various funds, with comparisons to the same period in 2025. Notable funds include the Preferred Income Fund, Income Securities Trust, and Tax-Advantaged Dividend Income Fund. The report emphasizes that past earnings do not guarantee future results.

MorningStar

John Hancock Tax-Advantage Div

John Hancock Income Trust

John Hancock Pfd Income

MANULIFE-S

John Hancock Inc ll

John Hancock Pfd Income lll

John Hancock Investors Trust

John Hancock Premium Div Fd

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Manulife's report urges global reform of retirement systems to adapt to increasing life expectancy and longer retirement periods. It highlights the risks of overly conservative investment strategies, suggesting that retirees could lose over USD 1,200 monthly income by relying solely on bonds. The report proposes five pillars for robust retirement systems, including sustainable income, inclusivity, flexible investment choices, advisory support, and transparency.

AASTOCKS News

Manulife: Excessively Conservative Retirement Investing Carries Heavy Cost, Urges Global Reform of Retirement Systems

00945

Manulife Singapore will launch the Shield™ multi-cancer detection test in May 2026 through its partnership with Guardant Health, becoming the first in Singapore to offer this blood test for multiple cancers. This initiative supports preventive healthcare, addressing the rising demand for early cancer detection. The Shield™ test has received Breakthrough Device Designation from the FDA and was recognized as Oncology Product Innovation of the Year. Manulife aims to empower customers in managing their health and finances.

Singapore Business Review

Guardant Health

Ark Genomic Revolution ETF

E Fund CSI Biotechnology Theme ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Minsheng Royal CSI Biotechnology Theme ETF

VanEck Biotech ETF

ChinaAMC CSI Biotechnology Theme ETF

Hwabao WP CSI Medical Service ETF

Direxion S&P Biotech Bull 3X

China Merchants CSI Biotechnology Theme ETF

Direxion S&P Biotech Bear 3X

Manulife Singapore to offer multi-cancer blood test starting May

INTC

SOXL

SOXX

INTW

CFRA maintains a Buy opinion on Intel Corporation, raising the 12-month target price to $130 from $100. The firm increased EPS estimates for 2026 to $1.20 and for 2027 to $1.60, citing strong revenue and margin growth potential driven by AI demand and extended CPU lead times. Gross margins are expected to exceed 50% by 2027/2028, with additional foundry orders anticipated in the second half of the year.

- CFRA has raised its 12-month target price for a company to $130, predicting an EPS increase for 2026 and 2027 due to favorable margin expectations linked to CPU market shifts towards AI.  
- The analysts anticipate gross margins exceeding 50% by 2027/2028, driven by extended lead times and pricing pressures in the CPU market.  
- Additionally, INTC is expected to secure more foundry orders, enhancing its long-term growth prospects.

fidelity

Intel

VanEck Semiconductor ETF

Direxion Semicon Bull 3X

iShares Semiconductor ETF

SPDR S&P Semicon

GraniteShares 2x Long INTC Daily ETF

Research Alert: CFRA Maintains Buy Opinion On Shares Of Intel Corporation

CFRA maintains a Buy opinion on Manulife Financial Corp. with a 12-month target price of CAD57. The company reported Q1 2026 core EPS of CAD1.06, exceeding last year's CAD0.99, while net income rose to CAD1.147B. Asia's performance was strong, with core earnings up 22%. Currently, shares are trading at a discount, yielding 3.3%, indicating they are undervalued.

Research Alert: CFRA Keeps Buy Opinion On Shares Of Manulife Financial Corp.

Manulife Financial Corporation announced the election of 13 directors at its Annual Meeting of Shareholders. The nominees received significant support, with votes for each ranging from 95.37% to 99.82%. The final voting results will be available on their website and filed with securities regulators. Manulife is a leading international financial services provider, operating as Manulife in Canada and Asia, and John Hancock in the U.S., serving over 37 million customers globally.

StockTitan

Manulife Announces Election of Directors | MFC Stock News

Manulife Financial(MFC.US)